Infynity Biomarkers, France
President & CSO
Throughout his 30+ year scientific career, Dr Maan has spearheaded a wide range of applied research programs in the field of infectious diseases and biomarkers. Research undertaken by his company INFYNITY Biomarkers has led to peer-reviewed scientific publications in international journals including PLoS series, Transfusion, Vaccine, etc. His company is also recognized as one of the leading experts in identifying immune-dominant protein sequences (epitope mapping) securing six patent families that are valorized world-wide by international industry players.
After completing a PhD in immunochemistry at the University Louis Pasteur, Strasbourg, France with a focus on immunodiagnostics for pathogen, Dr. Maan embraced his career in industrial R&D in Canada where he directed R&D and developed programs applied to the IVD industry that have been marketed worldwide. Dr. Maan is a passionate science communicator, contributing to a wide range of international conferences and Symposium as a speaker.